Debya

Chairman Kefka

Chairman Kefka

chairmankefka.bsky.social

Final Boss | Head of Party | God of Magic | Never Financial Advice only opinions

👤 Joined on 19 novembro 2023

1432

Followers

2695

Following

444

Total Posts

📜 Kullanıcı Geçmişi

  • 19 Kas 2023, 16:25
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @0xkefka.bsky.social
  • 16 Kas 2024, 01:20
    ✏️ Kullanıcı adı değişti: @0xkefka.bsky.social → @chairmankefka.bsky.social

❤️ Beğendiği Gönderiler

Ed Zitron
30 outubro 2026 21:52

It’s almost as if - apologies for repeating myself for years - AI does not have financial returns commensurate with its costs and, indeed, actually makes the products worse.

Show Post
Jessica Pickett
29 outubro 2026 06:07

Quite a pivot from earlier statements about focusing solely on preclinical research on “unprofitable” diseases, though — and much harder to argue that pharma should view Claude as a tool rather than a competitive threat. Alternate read: ✨hubris✨

Show Post
Jessica Pickett
29 outubro 2026 06:07

I will take them seriously when they hire someone with actual industry or regulatory experience, and stop conflating those with a Twitter MBA

Show Post
?
29 outubro 2026 06:06

Yeah I know those companies have large number of contracts; there was a case in the mid-90s about how MS treated theirs. Each of those companies still have large staff, IP, etc. This is just a guy who outsourced all of the work to a bunch of different labs with no real IP.

Show Post
29 outubro 2026 06:06

LOL. sure why not .. still used 8 consultants

Show Post
Daha fazlası için üye girişi yap

Selecionar Idioma